1. Home
  2. ADP vs SNY Comparison

ADP vs SNY Comparison

Compare ADP & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Automatic Data Processing Inc.

ADP

Automatic Data Processing Inc.

N/A

Current Price

$266.79

Market Cap

98.2B

Sector

Technology

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$44.39

Market Cap

104.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ADP
SNY
Founded
1949
1994
Country
United States
France
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.2B
104.5B
IPO Year
2005
2001

Fundamental Metrics

Financial Performance
Metric
ADP
SNY
Price
$266.79
$44.39
Analyst Decision
Hold
Buy
Analyst Count
14
5
Target Price
$275.57
$58.00
AVG Volume (30 Days)
2.3M
3.3M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
3.16%
3.47%
EPS Growth
9.62
N/A
EPS
10.94
N/A
Revenue
$21,947,400,000.00
N/A
Revenue This Year
$7.08
$3.49
Revenue Next Year
$5.69
$6.10
P/E Ratio
$24.95
$6.14
Revenue Growth
6.74
N/A
52 Week Low
$188.16
$40.89
52 Week High
$310.08
$52.68

Technical Indicators

Market Signals
Indicator
ADP
SNY
Relative Strength Index (RSI) 55.47 57.47
Support Level $247.23 $42.30
Resistance Level $280.59 $45.22
Average True Range (ATR) 7.35 0.65
MACD -1.02 0.08
Stochastic Oscillator 40.44 69.26

Price Performance

Historical Comparison
ADP
SNY

About ADP Automatic Data Processing Inc.

Automatic Data Processing, or ADP, is a global, cloud-based human capital management provider offering payroll, compliance, talent management, benefits administration, and retirement services. The firm also provides HR outsourcing services, including PEO offerings, enabling clients to reduce HR overhead. Its broad suite serves customers of all sizes across diverse sectors, and the firm holds large market shares in its core markets. As of fiscal 2025, ADP counts over 1.1 million clients and manages payroll for more than 42 million workers across 140 countries.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: